In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Drug:  lintuzumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: PDL-195-301, MSKCC-00029, UCLA-9910050, NCI-G00-1819, NCT00006045

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor:
Protocol IDs: MSKCC-93111, NCI-V94-0350

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 12
Sponsor:
Protocol IDs: MSKCC-93117, NCI-V94-0359

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: MSKCC-94088A3, NCI-H94-0571, NCT00002609

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 16
Sponsor:
Protocol IDs: MSKCC-95009, NCI-V95-0631

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-96044, NCI-V96-0941, NCT00002800

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-97103, PDL-3-201, NCI-G97-1367

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068076, P30CA016042, UCLA-9910096, PDL-195-302, NCI-G00-1823, NCT00006084

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 00-072, MSKCC-00072, NCI-H01-0073, NCT00016159

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor:
Protocol IDs: MSKCC-93083, NCI-V93-0315

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG033-0003, NCT00528333

13.

Phase: Phase I
Type: Treatment
Status: Closed
Age: physiologic 50 and under
Sponsor: Other
Protocol IDs: MSKCC-93132, NCI-V94-0358

14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: Other
Protocol IDs: MSKCC-95043, NCI-V95-0709

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MSKCC-96003A1, NCI-T95-0026H, T95-0026

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: MSKCC-96010, NCI-H96-1100, NCT00002890

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-96014A1, NCI-H96-1101

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: over 12
Sponsor:
Protocol IDs: MSKCC-92088, NCI-V92-0130

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DM98-342, NCT00038051

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG033-0001, NCT00283114

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG033-0002, NCT00502112
New Search